8-KEarnings & ResultsExhibits & Filings

GILEAD SCIENCES, INC. 8-K Report, Financial Results (Aug 4, 2026)

Filed August 4, 2026For Securities:GILD

Summary

Gilead Sciences, Inc. (GILD) has reported its financial results for the second quarter ended June 30, 2026. The company has provided both GAAP and non-GAAP financial measures, with management emphasizing that non-GAAP figures are useful for investors when viewed alongside GAAP statements, as they are used internally for operational and financial planning. Investors are advised to consult the reconciliation tables provided in the accompanying press release for a comprehensive understanding of the differences between GAAP and non-GAAP reporting. This 8-K filing primarily serves to announce these results and direct investors to the detailed press release. While the filing itself doesn't present the specific financial figures, it signifies the disclosure of Gilead's quarterly performance. Investors should refer to Exhibit 99.1 for the complete financial details, including revenue, earnings, and other key performance indicators, as well as management's commentary on business developments and outlook.

Key Highlights

  • 1Gilead Sciences announced its Q2 2026 financial results on August 4, 2026.
  • 2The company reported results for the quarter ended June 30, 2026.
  • 3Gilead presented financial information using both GAAP and non-GAAP measures.
  • 4Management believes non-GAAP measures offer useful insights for investors.
  • 5Non-GAAP information is used internally for operating, budgeting, and financial planning.
  • 6A reconciliation between GAAP and non-GAAP financial information is available in the press release.
  • 7The press release detailing the financial results is filed as Exhibit 99.1 to this 8-K.

Frequently Asked Questions

The primary purpose of this 8-K filing is to announce Gilead Sciences' financial results for the second quarter ended June 30, 2026, and to provide investors with access to the detailed press release containing these results.

The specific financial results, including revenue, earnings, and other key metrics, are detailed in the press release filed as Exhibit 99.1 to this 8-K filing. It is recommended to review this exhibit for comprehensive financial data.

Gilead presents its financial results using both Generally Accepted Accounting Principles (GAAP) and non-GAAP measures. Management uses non-GAAP measures internally for operational and financial planning, and believes they can be useful to investors. A detailed reconciliation explaining the differences between the two reporting methods is provided in the press release (Exhibit 99.1).

No, the information in Item 2.02 and Item 9.01 of this Form 8-K, and Exhibit 99.1, is not deemed 'filed' for the purposes of Section 18 of the Securities Exchange Act of 1934, nor is it subject to the liabilities under that section. It is intended to provide timely disclosure of material information.